These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

210 related items for PubMed ID: 36611052

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Coronavirus Susceptibility to the Antiviral Remdesivir (GS-5734) Is Mediated by the Viral Polymerase and the Proofreading Exoribonuclease.
    Agostini ML, Andres EL, Sims AC, Graham RL, Sheahan TP, Lu X, Smith EC, Case JB, Feng JY, Jordan R, Ray AS, Cihlar T, Siegel D, Mackman RL, Clarke MO, Baric RS, Denison MR.
    mBio; 2018 Mar 06; 9(2):. PubMed ID: 29511076
    [Abstract] [Full Text] [Related]

  • 23. Structural and molecular basis of mismatch correction and ribavirin excision from coronavirus RNA.
    Ferron F, Subissi L, Silveira De Morais AT, Le NTT, Sevajol M, Gluais L, Decroly E, Vonrhein C, Bricogne G, Canard B, Imbert I.
    Proc Natl Acad Sci U S A; 2018 Jan 09; 115(2):E162-E171. PubMed ID: 29279395
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. The coronavirus proofreading exoribonuclease mediates extensive viral recombination.
    Gribble J, Stevens LJ, Agostini ML, Anderson-Daniels J, Chappell JD, Lu X, Pruijssers AJ, Routh AL, Denison MR.
    PLoS Pathog; 2021 Jan 09; 17(1):e1009226. PubMed ID: 33465137
    [Abstract] [Full Text] [Related]

  • 26. Ritonavir may inhibit exoribonuclease activity of nsp14 from the SARS-CoV-2 virus and potentiate the activity of chain terminating drugs.
    Narayanan N, Nair DT.
    Int J Biol Macromol; 2021 Jan 31; 168():272-278. PubMed ID: 33309661
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Refolding of lid subdomain of SARS-CoV-2 nsp14 upon nsp10 interaction releases exonuclease activity.
    Czarna A, Plewka J, Kresik L, Matsuda A, Karim A, Robinson C, O'Byrne S, Cunningham F, Georgiou I, Wilk P, Pachota M, Popowicz G, Wyatt PG, Dubin G, Pyrć K.
    Structure; 2022 Aug 04; 30(8):1050-1054.e2. PubMed ID: 35609600
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Structural basis of mismatch recognition by a SARS-CoV-2 proofreading enzyme.
    Liu C, Shi W, Becker ST, Schatz DG, Liu B, Yang Y.
    Science; 2021 Sep 03; 373(6559):1142-1146. PubMed ID: 34315827
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Structure-Based Virtual Screening for Methyltransferase Inhibitors of SARS-CoV-2 nsp14 and nsp16.
    Wu K, Guo Y, Xu T, Huang W, Guo D, Cao L, Lei J.
    Molecules; 2024 May 15; 29(10):. PubMed ID: 38792173
    [Abstract] [Full Text] [Related]

  • 33. Coronavirus 2'-O-methyltransferase: A promising therapeutic target.
    Schindewolf C, Menachery VD.
    Virus Res; 2023 Oct 15; 336():199211. PubMed ID: 37634741
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Coronaviruses lacking exoribonuclease activity are susceptible to lethal mutagenesis: evidence for proofreading and potential therapeutics.
    Smith EC, Blanc H, Surdel MC, Vignuzzi M, Denison MR.
    PLoS Pathog; 2013 Aug 15; 9(8):e1003565. PubMed ID: 23966862
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Proofreading-Deficient Coronaviruses Adapt for Increased Fitness over Long-Term Passage without Reversion of Exoribonuclease-Inactivating Mutations.
    Graepel KW, Lu X, Case JB, Sexton NR, Smith EC, Denison MR.
    mBio; 2017 Nov 07; 8(6):. PubMed ID: 29114026
    [Abstract] [Full Text] [Related]

  • 40. Synthetic Platforms for Characterizing and Targeting of SARS-CoV-2 Genome Capping Enzymes.
    Ornelas MY, Thomas AY, Johnson Rosas LI, Scoville RO, Mehta AP.
    ACS Synth Biol; 2022 Nov 18; 11(11):3759-3771. PubMed ID: 36331143
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.